PTHLH and neoplasm: The proliferation of tumor cells in the bone microenvironment disrupts the delicate balance of bone remodeling by releasing substances such as interleukins (ILs) and parathyroid hormone-related protein (PTHrP), which prompt osteoblasts to increase the synthesis of receptor activator of NF-κB ligand (RANKL).